Nanocarriers loaded with photosensitizers and others drugs derived of growth factors applied to Photodynamic Processes in treatment of central nervous system diseases

• Grant number: 18/24004-9
• Support type: Scholarships in Brazil - Post-Doctorate
• Effective date (Start): February 01, 2019
• Effective date (End): May 31, 2020
• Field of knowledge: Health Sciences - Pharmacy - Pharmaceutical Technology
• Principal researcher: Antonio Claudio Tedesco
• Grantee: Leonardo Barcelos de Paula
• Home Institution: Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto (FFCLRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
• Associated research grant: 13/50181-1 - Use of drugs containing nanocarriers with photosensitizers and/or other active compounds applied to cell therapy and treatment of central nervous system disorders, AP.TEM

Abstract

It is estimated that approximately 1.5 billion people worldwide suffer with some kind of disorder of the central nervous system (CNS). Therefore, there is a high demand for effective treatments. Due to an increase in the number of elderly in the world population, if there is an increase or improvement of existing treatments, the number of people with diseases of the CNS will be approximately 1.9 billion by 2020. Among the major CNS diseases are solid tumors, cerebrovascular accident (CVA) and vasospasm of cerebral arteries. Among the tumors that affect the CNS, glioma is the most aggressive and frequent accounting for 50% of all tumors with survival less than one year. Other serious problems are called cerebrovascular accident (CVA), which is the second leading cause of death in Brazil and vasospasm of cerebral arteries, resulting from subarachnoid hemorrhage. All currently existing treatments for brain affections reported here are not very effective, resulting in a large number of patients with serious neurological damage or death. Therefore, the need to develop a more effective therapy. This project is divided into 5 sub-projects, three related to glioma, one related to stroke and another related to vasospasm of cerebral arteries. Thus, the studies proposed in this project seem very relevant, since the use of new technologies, on a theme already explored, but with little success, seems to be the key to the discovery of new therapeutic strategies. Therefore, the common guideline that unites all proposals is the combination of Nanotechnology, Fotoprocesso and Cell Therapy for the treatment of CNS diseases.

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

PELLOSI, DIOGO S.; PAULA, LEONARDO B.; DE MELO, MARYANNE T.; TEDESCO, ANTONIO C. Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy. MOLECULAR PHARMACEUTICS, v. 16, n. 3, p. 1009-1024, MAR 2019. Web of Science Citations: 4.